Laboratory Centrifuge Market to Reach $2.9 Billion by 2032
The laboratory centrifuge market is projected to grow from $1.9 billion in 2022 to $2.9 billion by 2032. Growth is attributed to increasing disease prevalence and R&D activities.
The global laboratory centrifuge market is expected to reach $2.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2023 to 2032. In 2022, the market was valued at $1.9 billion. Laboratory centrifuges are essential laboratory equipment used for separating substances based on density, size, and shape through centrifugal force.
The market's expansion is driven by several factors, including the rising prevalence of diseases, an increase in clinical diagnoses, and a surge in research and development activities within the life sciences and biotechnology sectors. Technological advancements, such as the development of high-throughput and automated centrifuge systems, also contribute to market growth. Furthermore, the growing demand for blood components, crucial for blood banking and medical diagnostics, is a significant driver.
While the high cost of laboratory centrifuges may pose a restraint, factors like increased R&D investments, rising capital income in developed nations, and strategic initiatives by key players, such as acquisitions and partnerships, are expected to propel the market forward. For instance, Thermo Fisher Scientific launched its single-use DynaSpin centrifuge system in 2022.
The accessories segment is anticipated to experience the highest CAGR due to recurring purchases for research and diagnostic applications. Benchtop centrifuges are also expected to see strong growth, particularly favored by laboratories with limited space.